IDEA
Latest round
- Series D
Last raised
- Feb 2005
Total raised
- $0.9M
Investors
- 4
About IDEA
IDEA AG, a biopharmaceutical company, develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs. The company uses Transfersome cariers for transporting the established molecular weight drugs selectively into the skin.
Who invested in IDEA
4 investors across 1 round
See all investors in IDEA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Feb 18, 2005
Amount
$0.9M
Investors
Questions about IDEA
Who invested in IDEA?
IDEA has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IDEA raised?
IDEA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IDEA last raise money?
IDEA's most recent round on record is a Series D, in Feb 2005.
What does IDEA do?
IDEA AG, a biopharmaceutical company, develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs.
Where is IDEA headquartered?
IDEA is headquartered in Munich, Germany.
Which VCs invest in companies like IDEA?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at IDEA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like IDEA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.